{
    "2021-02-10": [
        [
            {
                "time": "2021-01-01",
                "original_text": "法院许可海航控股在重整期间继续营业并自行管理财产",
                "features": {
                    "keywords": [
                        "海航控股",
                        "重整",
                        "继续营业",
                        "自行管理"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "航空运输"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-01-01",
                "original_text": "定增市场2021年1月报：竞价折价率高位回落 新规下待解禁竞价六成浮盈",
                "features": {
                    "keywords": [
                        "定增市场",
                        "竞价折价率",
                        "新规",
                        "浮盈"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-10",
                "original_text": "华大基因：和玉高林和高林同创拟减持不超过约207万股 拟减持股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "减持",
                        "和玉高林",
                        "高林同创"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-10",
                "original_text": "华大基因：华大投资拟减持公司不超过约828万股股份 拟减持股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "减持",
                        "华大投资"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-10",
                "original_text": "华大基因：子公司两项新冠检测产品获欧盟CE准入资质",
                "features": {
                    "keywords": [
                        "华大基因",
                        "新冠检测",
                        "CE准入",
                        "资质"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-10",
                "original_text": "华大基因：子公司已与NUPCO签署修订协议等等追加约8280万美元合同金额",
                "features": {
                    "keywords": [
                        "华大基因",
                        "NUPCO",
                        "合同金额",
                        "追加"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-10",
                "original_text": "新冠检测概念走强，贝瑞基因涨停，华大基因等大涨",
                "features": {
                    "keywords": [
                        "新冠检测",
                        "贝瑞基因",
                        "华大基因",
                        "涨停"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}